Short-acting beta-adrenergic blockade and the fetus: A case report

G. J. Gilson; K. J. Knieriem; J. F. Smith; L. Izquierdo; M. S. Chatterjee; L. B. Curet

Back

Short-acting beta-adrenergic blockade and the fetus: A case report

Journal article

Peer reviewed

Short-acting beta-adrenergic blockade and the fetus: A case report

G. J. Gilson, K. J. Knieriem, J. F. Smith, L. Izquierdo, M. S. Chatterjee and L. B. Curet

Journal of Reproductive Medicine for the Obstetrician and Gynecologist, Vol.37(3), pp.277-279

01/01/1992

PMID: 1348787

Abstract

Reproductive Medicine

Obstetrics and Gynecology

An infant was born to a woman who received intravenous esmolol for intrapartum supraventricular tachyarrhythmia. Despite the very short acting and cardioselective beta-1 adrenergic blockade induced by that agent, neonatal effects can occur up to 48 hours after delivery.

Metrics

5 Record Views

Details

Title: Short-acting beta-adrenergic blockade and the fetus
Creators: G. J. Gilson (Author) - University of New Mexico
K. J. Knieriem (Author) - University of New Mexico
J. F. Smith (Author) - University of New Mexico
L. Izquierdo (Author) - University of New Mexico
M. S. Chatterjee (Author) - University of New Mexico
L. B. Curet (Author) - University of New Mexico
Publication Details: Journal of Reproductive Medicine for the Obstetrician and Gynecologist, Vol.37(3), pp.277-279
Series: 37
Number of pages: 3
Identifiers: 991005930469602656
Academic Unit: Creighton University
Language: English
Resource Type: Journal article

Short-acting beta-adrenergic blockade and the fetus: A case report

Abstract

Related links

Metrics

Details